%0 Journal Article
%T The efficacy of adding budesonide/formoterol to ipratropium plus
theophylline in managing severe chronic obstructive pulmonary disease: an
open-label, randomized study in China
%A Chen Wang
%A Hongyang Wang
%A Jian Kang
%A Kewu Huang
%A Li An
%A Lijun Ma
%A Liping Peng
%A Rong Su
%A Yanfei Guo
%A Yohji Itoh
%A Zeguang Zheng
%J Archive of "Therapeutic Advances in Respiratory Disease".
%D 2019
%R 10.1177/1753466619853500
%X Patients diagnosed with chronic obstructive pulmonary disease (COPD) in China are commonly prescribed ipratropium plus theophylline (I+T) therapy. Studies have shown that an inhaled corticosteroid (ICS)/long-acting ¦Â2-agonist (LABA) combination is also efficacious in reducing symptoms and exacerbations. This study evaluated the efficacy and tolerability of adding budesonide/formoterol (BUD/FORM) to I+T in Chinese patients with severe COPD
%K antimuscarinic
%K budesonide
%K COPD
%K formoterol
%K glucocorticoid
%K methylxanthine
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595664/